Document Detail


Chemical pregnancies: immunologic and ultrasonographic studies.
MedLine Citation:
PMID:  12516655     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PROBLEM: Implantation of the embryo determines successful from unsuccessful cycles after in vitro fertilization (IVF) and embryo transfer (ET). The purpose of this study was to compare immunologic risk factors among women experiencing implanation failure characterized by a negative pregnancy test after IVF/ET and those experiencing chemical pregnancies. In addition ultrasonographic measurement of gestational sac size from 24 to 35 days from last menstrual period (LMP) were compared between chemical pregnancies and other pregnancy outcomes. METHODS OF STUDY: Blood samples from 122 women experiencing IVF implantation failure with a negative pregnancy test after ET and 20 women with chemical pregnancies were evaluated for the presence of antiphospholipid antibodies (APA), antinuclear antibodies (ANA), circulating embryotoxins (ETA) and elevated levels of natural killer (NK) cells. Gestational sac size measured from 24 to 35 days form LMP were compared according to pregnancy outcome: term birth (n = 46), ectopic pregnancy (n = 49), spontaneous abortion (n = 56) and chemical pregnancy (n = 20). RESULTS: Women experiencing chemical pregnancies had a higher frequency of APA than women with implantation failure associated with a negative pregnancy test (80% versus 28%, P < 0.0001). The prevalence of ANA, elevated NK cells and ETA was not different between the two groups. The mean gestational sac size from 24 to 35 days from LMP did not differ when chemical pregnancies were compared with pregnancies progressing longer than 35 days. The maximal gestational sac diameter among chemical pregnancies was 3.8 mm. CONCLUSION: Mechanisms involved in implantation failure associated with a negative pregnancy test may be different from those involved in chemical pregnancies. Chemical pregnancies may be the result of defective angiogenesis.
Authors:
Carolyn B Coulam; Roumen Roussev
Related Documents :
10632425 - Where does the embryo implant after embryo transfer in humans?
3609345 - Reduction of the number of embryos in a multiple pregnancy: quintuplet to triplet.
2511975 - Outcome of pregnancies referred to a general practitioner maternity unit in a district ...
12625425 - The monitoring of bovine pregnancies derived from transfer of in vitro produced embryos.
14617365 - Thrombophilia and pregnancy.
1294405 - Prediction of light-for-gestational age at delivery in twin pregnancies: an evaluation ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of reproductive immunology (New York, N.Y. : 1989)     Volume:  48     ISSN:  1046-7408     ISO Abbreviation:  Am. J. Reprod. Immunol.     Publication Date:  2002 Nov 
Date Detail:
Created Date:  2003-01-08     Completed Date:  2003-04-16     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8912860     Medline TA:  Am J Reprod Immunol     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  323-8     Citation Subset:  IM    
Affiliation:
Sher Institute for Reproductive Medicine and Millenova Immunology Laboratories, Chicago, IL 60610, USA. cbcoulam@aol.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortion, Habitual / immunology
Amnion / anatomy & histology,  ultrasonography
Antibodies / blood,  immunology
Female
Fertilization in Vitro*
Humans
Phospholipids / immunology
Pregnancy / immunology*
Pregnancy Outcome*
Risk Factors
Chemical
Reg. No./Substance:
0/Antibodies; 0/Phospholipids

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  High serum interleukin-8 levels in afro-caribbean women with pre-eclampsia. Relations with tumor nec...
Next Document:  Immunosuppressive properties of follicular fluid and media conditioned by zygotes correlate with sub...